NASDAQ:XGN

Exagen Stock Predictions

Healthcare > Medical - Diagnostics & Research

Buy XGN

*Your capital is at risk

$4.54

-0.280 (-5.81%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

XGN Prediction Chart

XGN Predictions History

Latest community submissions for XGN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
RamboRex3000 Pro	Aug 18, 2021	$12.85 -2.43%	$13.17	X	97.57%	0
JS Pro	Aug 18, 2021	$13.08 -0.68%	$13.17	X	99.32%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XGN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT EXAGEN INC.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by